XML 58 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Stock-based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Stockholders' Equity        
Stock-based compensation expense $ 7,112 $ 6,898 $ 21,528 $ 20,986
RSU        
Stockholders' Equity        
Unrecognized compensation cost $ 20,600   $ 20,600  
Weighted-average period     1 year 9 months 18 days  
Shares        
Nonvested at the beginning of the period (in shares)     427,447  
Granted (in shares)     356,694  
Vested (in shares)     (312,038)  
Forfeited (in shares)     (13,814)  
Nonvested at the end of the period (in shares) 458,289   458,289  
Weighted-Average Fair Value        
Nonvested at the beginning of the period (in dollars per share)     $ 90.17  
Granted (in dollars per share)     89.11  
Vested (in dollars per share)     96.42  
Forfeited (in dollars per share)     88.82  
Nonvested at the end of the period (in dollars per share) $ 85.13   $ 85.13  
Stock Options        
Stockholders' Equity        
Unrecognized compensation cost $ 800   $ 800  
Weighted-average period     2 years 2 months 12 days  
Number of Options        
Outstanding at the beginning of the period (in shares)     110,645  
Granted (in shares)     23,351  
Exercised (in shares)     (19,614)  
Expired or forfeited (in shares)     (1,568)  
Outstanding at the end of the period (in shares) 112,814   112,814  
Exercisable at the end of the period (in shares) 67,689   67,689  
Weighted Average Exercise Price        
Outstanding at the beginning of the period (in dollars per share)     $ 82.43  
Granted (in dollars per share)     87.90  
Exercised (in dollars per share)     67.83  
Expired or forfeited (in dollars per share)     81.60  
Outstanding at the end of the period (in dollars per share) $ 86.11   $ 86.11  
Weighted-Average Remaining Contractual Term        
Outstanding at the end of the period     6 years 9 months 18 days  
Exercisable at the end of the period     5 years 4 months 24 days  
Aggregate Intrinsic Value        
Outstanding at the end of the period $ 1,833   $ 1,833  
Exercisable at the end of the period $ 1,274   $ 1,274  
Performance-based restricted stock units        
Shares        
Granted (in shares)     110,811 96,620
Performance-based restricted stock units | Minimum        
Stockholders' Equity        
Payout as a percentage of the original number of shares awarded or units awarded, which are converted into shares of the company's common stock     0.00%  
Performance-based restricted stock units | Maximum        
Stockholders' Equity        
Payout as a percentage of the original number of shares awarded or units awarded, which are converted into shares of the company's common stock     376.00%  
OSI Plans        
Stockholders' Equity        
Shares available for grant 800,000   800,000  
OSI Plans | RSU        
Stockholders' Equity        
Number of shares available for grant reduced for each award granted     1.87  
Number of shares available for grant increased for each award forfeited and returned     1.87  
Cost of goods sold        
Stockholders' Equity        
Stock-based compensation expense $ 229 205 $ 686 $ 616
Selling, general and administrative        
Stockholders' Equity        
Stock-based compensation expense 6,757 6,567 20,467 19,977
Research and development        
Stockholders' Equity        
Stock-based compensation expense $ 126 $ 126 $ 375 $ 393